Fundraising Fox

Cytoki Pharma

Værløse, DK · 3 known investors

Cytoki Pharma is a clinical-stage biotechnology company developing IL-22-based medicines for metabolic diseases such as obesity and type 2 diabetes, and conditions involving epithelial injury like inflammatory bowel disease. Its lead candidate, CK-0045, is a long-acting IL-22 analogue in Phase 2 clinical evaluation for cardiometabolic diseases.

BiotechHealthtech

Founders & leadership

RJ
Rasmus JorgensenFounder

Investors · 3

+ND CapitalWoodside · $540K – $5.4M
Ysios CapitalBarcelona · $5.4M – $21.6M
Seventure PartnersreportedParis

In the news

Cytoki Pharma Announces Positive Phase1 Data – Ysios Capitalysioscapital.com · Jul 2024Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND Capital - Webcapitalriesgowebcapitalriesgo.com · May 2021Cytoki Pharma raises $45million Series A financing | The Lundbeck Foundationlundbeckfonden.com · May 2021Ysios Capital joins 38M€ Series A financing of Cytokiysioscapital.com · May 2021BioCentury - Cytoki’s IL-22 program wins support from European syndicate in $45M series A, moves toward clinic for IBDbiocentury.com · May 2021Cytoki Pharma - Damalion - Independent Consulting Corporation.damalion.com

Frequently asked questions

What does Cytoki Pharma do?
Cytoki Pharma is a clinical-stage biotechnology company developing IL-22-based medicines for metabolic diseases such as obesity and type 2 diabetes, and conditions involving epithelial injury like inflammatory bowel disease. Its lead candidate, CK-0045, is a long-acting IL-22 analogue in Phase 2 clinical evaluation for cardiometabolic diseases.
Who founded Cytoki Pharma?
Cytoki Pharma was founded by Rasmus Jorgensen.
Who are Cytoki Pharma's investors?
Cytoki Pharma's investors include +ND Capital, Ysios Capital, Seventure Partners.
Where is Cytoki Pharma headquartered?
Cytoki Pharma is headquartered in Værløse, DK.